Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Manulife US REIT ( (SG:BTOU) ) has shared an announcement.
Manulife US Real Estate Investment Trust has announced amendments to its Master Restructuring Agreement, following the requisite consent from lenders. This includes the approval for the sale of the Peachtree property in Atlanta, Georgia, as part of its strategy to divest non-core assets to meet a minimum sale target of US$328.7 million by June 2025. The divestment is a part of the trust’s recapitalization plan aimed at reducing aggregate leverage, which could impact its financial stability and market positioning.
The most recent analyst rating on (SG:BTOU) stock is a Buy with a $0.22 price target. To see the full list of analyst forecasts on Manulife US REIT stock, see the SG:BTOU Stock Forecast page.
More about Manulife US REIT
Manulife US Real Estate Investment Trust is a real estate investment trust established under the laws of the Republic of Singapore. The trust focuses on investing in a diversified portfolio of income-producing office real estate in key markets in the United States.
Average Trading Volume: 5,140,880
Technical Sentiment Signal: Strong Sell
Current Market Cap: $108.4M
For an in-depth examination of BTOU stock, go to TipRanks’ Stock Analysis page.

